| |
| Issue |
Title |
| |
| Vol 14, No 1 (2026) |
Chronic Obstructive Pulmonary Disease: Economic Burden in Russia and European Countries (Review) |
Abstract
PDF (Rus)
|
|
G. S. Rozanova, G. I. Zavitkevich, R. A. Bontsevich, M. L. Maximov |
| |
| Vol 14, No 1 (2026) |
Multi-Omics in Predicting Lamotrigine Neurotoxicity: Current Opportunities (Review) |
Abstract
PDF (Rus)
PDF (Eng)
|
|
N. A. Shnayder, V. V. Bader, R. F. Nasyrova, M. Ya. Kissin |
| |
| Vol 14, No 1 (2026) |
Safety of the First- and Second-Line Metastatic Triple-Negative Breast Cancer Chemotherapy: A Retrospective Study |
Abstract
PDF (Rus)
PDF (Eng)
|
|
O. V. Shatalova, L. M. Ganicheva, M. A. Boriskina |
| |
| Vol 14, No 1 (2026) |
Pharmacovigilance and Ranitidine Withdrawal Awareness among Libyan Private Pharmacies (Gharyan): A Cross-Sectional Study |
Abstract
PDF (Eng)
|
|
A. A. Abeed, A. M. Abousaken, F. M. Abd alwafy, K. M. Akef, M. A. Artail, R. M. Aboabdulla |
| |
| Vol 14, No 1 (2026) |
Gonadotropin-Releasing Hormone and the Urinary System: Analyzing Contradictory Findings of Efficacy and Safety Studies (Review) |
Abstract
PDF (Rus)
|
|
I. V. Maiborodin, B. V. Sheplev, E. S. Chernomortseva, I. Yu. Fedina, V. I. Maiborodina |
| |
| Vol 14, No 1 (2026) |
Reporter vs Marketing Authorization Holder in Seriousness Assessment of Adverse Drug Reactions for Insulin Preparations: A Retrospective Analysis |
Abstract
PDF (Rus)
|
|
A. A. Ilyenkov, A. V. Philippova, I. K. Tuev, R. V. Drai, E. V. Lantsova |
| |
| Vol 14, No 1 (2026) |
Open-Access Adverse Drug Reaction Databases: Applicability for Safety Assessment of the Developed Drugs (Review) |
Abstract
PDF (Rus)
|
|
P. I. Savosina, V. V. Poroikov, D. S. Druzhilovskiy |
| |
| Vol 14, No 1 (2026) |
Therapeutic and Prophylactic Bacteriophage Preparations: Efficacy, Safety, and International Regulatory Experience (Review) |
Abstract
PDF (Rus)
|
|
R. E. Kazakov, S. Yu. Serebrova, E. Yu. Esakova, M. V. Zhuravleva, A. B. Prokofiev |
| |
| Vol 14, No 1 (2026) |
VKontakte Social Network as a Data Source for Pharmacovigilance: Applicability for Marketing Authorization Holders |
Abstract
PDF (Rus)
|
|
E. K. Nezhurina, K. S. Milchakov, A. A. Abramova |
| |
| Vol 14, No 1 (2026) |
Lasmiditan as the First and Only Representative of a New Class of Neuroactive Anti-Migraine Medications: A Review |
Abstract
PDF (Rus)
|
|
I. A. Mazerkina, R. N. Alyautdin |
| |
| 1 - 10 of 10 Items |
|
